Literature DB >> 32132065

Metastatic Malignant Peripheral Nerve Sheath Tumor With NF1 Successfully Treated With 'Gradual Subtraction' ICE Chemotherapy.

Yiqing Wang1,2, Hirohisa Katagiri3, Hideki Murata1, Junji Wasa1, Michihito Miyagi1, Yuko Kakuda4, Mitsuru Takahashi1.   

Abstract

BACKGROUND: Prognosis of metastatic malignant peripheral nerve sheath tumor (MPNST) is poor and the role of chemotherapy is controversial. There has been no report of metastatic MPNST with a good prognosis without surgery for metastases. CASE REPORT: A 40-year-old man with neurofibromatosis type 1 (NF1)-related MPNST on his shoulder with multiple lung metastases visited our hospital. After two cycles of chemotherapy with ifosfamide, carboplatin and etoposide (ICE), the primary lesion and lung metastases had shrunk. The primary lesion was resected with negative margins. Subsequently, 'gradual subtraction' ICE was administered, wherein the dose was reduced and the treatment interval was increased. After 14 courses of ICE over a period of 2 years, the lung metastases disappeared; there has been no recurrence for over 12 years.
CONCLUSION: ICE can be an excellent, inexpensive treatment for NF1-related MPNST. 'Gradual subtraction' chemotherapy allowed us to maintain long-term efficacy, induce tumor dormancy, and reduce side-effects. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  ICE chemotherapy; MPNST; NF1; Neurofibromatosis type I; malignant peripheral nerve sheath tumor

Year:  2020        PMID: 32132065     DOI: 10.21873/anticanres.14110

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  1 in total

1.  A rare case of cecal malignant peripheral nerve sheath tumor in a dog.

Authors:  Hyerin Ahn; Woo-Jin Song; Solji Choi; Jae-Hoon Kim; Ji-Youl Jung; Jongtae Cheong; Hyunjung Park; Hyohoon Jeong; Youngmin Yun
Journal:  J Vet Med Sci       Date:  2022-06-21       Impact factor: 1.105

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.